(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you are 16 or older with systemic lupus erythematosus and active kidney disease, you may qualify for this study of an investigational medication.
The research site is in Oklahoma City, Okla.
If you are an adult woman with resected node-positive or high-risk node-negative HER2-positive breast cancer, you may qualify for this study.
The research site is in Greeley, Colo.
If you are aged 50 to 80 with established atherosclerosis and are on a stable statin dose, you may be eligible for this study.
The research site is in New York City.
Copyright 2009 CenterWatch. All rights reserved.